Page last updated: 2024-12-10

1-palmitoyl-2-oleoylglycero-3-phosphoserine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1-Palmitoyl-2-oleoylglycero-3-phosphoserine (POPS)

**1-Palmitoyl-2-oleoylglycero-3-phosphoserine (POPS)** is a type of **phospholipid**, a class of lipids that are essential components of cell membranes. It is a **glycerophospholipid** specifically, meaning it has a glycerol backbone linked to two fatty acids and a phosphate group.

Here's a breakdown of its structure:

* **Glycerol backbone:** A three-carbon molecule that forms the core of the lipid.
* **Palmitic acid:** A saturated fatty acid with 16 carbon atoms attached to the first carbon of the glycerol backbone.
* **Oleic acid:** An unsaturated fatty acid with 18 carbon atoms and one double bond, attached to the second carbon of the glycerol backbone.
* **Phosphoserine:** A phosphate group linked to the amino acid serine, attached to the third carbon of the glycerol backbone.

**Why is POPS important for research?**

POPS plays a crucial role in various cellular processes, making it a significant target for research. Here are some key reasons:

* **Membrane structure and function:** POPS is a major component of cell membranes, contributing to their structural integrity and fluidity. It affects membrane permeability, protein interactions, and signal transduction pathways.
* **Cell signaling:** POPS acts as a signaling molecule involved in various cellular processes like cell growth, differentiation, and apoptosis.
* **Neurobiology:** POPS is abundant in the brain and plays a critical role in neuronal function and synaptic plasticity. It influences neurotransmitter release and neuronal communication.
* **Drug delivery:** POPS is used in research to develop drug delivery systems, leveraging its biocompatibility and ability to interact with cell membranes.
* **Model system:** POPS serves as a model system for studying the properties of phospholipids and their interactions with other molecules.

**Research involving POPS:**

Researchers are investigating POPS's role in various fields, including:

* **Understanding the mechanisms of membrane organization and function:** Researchers are studying how POPS interacts with other membrane components and how it contributes to membrane fluidity and permeability.
* **Investigating the role of POPS in cell signaling and disease:** Researchers are exploring how POPS contributes to signaling pathways and how its dysregulation can lead to diseases like cancer, neurodegenerative disorders, and cardiovascular disease.
* **Developing new drug delivery systems:** Researchers are leveraging POPS's properties to develop targeted drug delivery systems that can improve drug efficacy and reduce side effects.

**In conclusion,** 1-palmitoyl-2-oleoylglycero-3-phosphoserine (POPS) is a crucial phospholipid with diverse functions in cellular processes. Understanding its role in membrane structure, signaling, and disease is crucial for developing new therapies and advancing our understanding of biological processes.

{1-O-hexadecanoyl-2-O-[(Z)-octadec-9-enoyl]-sn-glycero-3-phospho}serine : A 3-sn-phosphatidyl-L-serine compound with a palmitoyl group at the 1-position and an oleoyl group at the 2-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5283499
CHEBI ID34086
SCHEMBL ID234216
MeSH IDM0143673

Synonyms (33)

Synonym
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylserine
l-serine, 3-[(1-oxohexadecyl)oxy]-2-[(1-oxo-9-octadecenyl)oxy]propyl hydrogen phosphate (ester), [r-(z)]-
ps(16:0/18:1(9z))
pops
ps(16:0/18:1)
LMGP03010024
1-hexadecanoyl-2-(9z-octadecenoyl)-sn-glycero-3-phosphoserine
palmitoyloleoyl-gps
o-(hydroxy{[(2r)-2-[(9z)-octadec-9-enoyloxy]-3-(hexadecanoyloxy)propyl]oxy}phosphoryl)-l-serine
1-palmitoyl-2-oleoyl-glycero-3-phosphoserine
{1-o-hexadecanoyl-2-o-[(z)-octadec-9-enoyl]-sn-glycero-3-phospho}serine
o-{[(2r)-3-(hexadecanoyloxy)-2-{[(9z)-octadec-9-enoyl]oxy}propoxy](hydroxy)phosphoryl}-l-serine
40290-44-6
1-palmitoyl-2-oleoylphosphatidylserine
CHEBI:34086
1-palmitoyl-2-oleoylglycero-3-phosphoserine
l-serine, 3-((1-oxohexadecyl)oxy)-2-((1-oxo-9-octadecenyl)oxy)propyl hydrogen phosphate (ester), (r-(z))-
pops lipid
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine
SCHEMBL234216
1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-l-serine
ps(16:0/18:1n9)
pser(16:0/18:1w9)
phosphatidylserine(16:0/18:1n9)
pser(16:0/18:1n9)
phosphatidylserine(16:0/18:1)
phosphatidylserine(16:0/18:1w9)
pser(16:0/18:1)
ps(16:0/18:1w9)
Q27115801
d39 ,
(2~{s})-2-azanyl-3-[[(2~{r})-3-hexadecanoyloxy-2-[(~{z})-octadec-9-enoyl]oxy-propoxy]-oxidanyl-phosphoryl]oxy-propanoic acid
DTXSID201229500
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
3-sn-phosphatidyl-L-serineA 3-sn-glycerophosphoserine compound having acyl substituents at the 1- and 2-hydroxy positions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (32)

PathwayProteinsCompounds
phospholipid biosynthesis CL(16:0/14:0/18:1(9Z)/14:0)1120
phospholipid biosynthesis CL(16:0/16:0/16:0/18:1(9Z))1122
phospholipid biosynthesis CL(16:0/16:0/18:1(9Z)/16:0)1122
phospholipid biosynthesis CL(16:0/16:1(9Z)/16:1(9Z)/18:1(9Z))1324
phospholipid biosynthesis CL(16:0/16:1(9Z)/18:1(9Z)/16:1(9Z))1324
phospholipid biosynthesis CL(16:0/18:1(9Z)/14:0/14:0)1120
phospholipid biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/16:1(9Z))1324
phospholipid biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(9Z))1121
phospholipid biosynthesis CL(16:1(9Z)/16:0/16:1(9Z)/18:1(9Z))1324
phospholipid biosynthesis CL(16:1(9Z)/16:0/18:1(9Z)/16:1(9Z))1324
phospholipid biosynthesis CL(16:1(9Z)/16:1(9Z)/18:1(9Z)/16:0)1324
Phosphatidylcholine Biosynthesis PC(16:0/18:1(9Z))620
Phosphatidylethanolamine Biosynthesis PE(16:0/18:1(9Z))516
Phosphatidylcholine/Phosphatidylethanolamine Biosynthesis PC(16:0/18:1(9Z)) | PE(16:0/18:1(9Z))617
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/14:0/14:0)324
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/14:0/16:0)324
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/14:0/18:1(9Z))323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:0/14:0)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:0/17:0cycw7)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:0/18:1(9Z))325
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:0/19:0cycw7)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/16:1(9Z))326
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/18:1(9Z))326
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/17:0cycw7/16:0)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/17:0cycw7/17:0cycw7)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/17:0cycw7/18:1(9Z))323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/14:0)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/16:0)327
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/16:1(9Z))326
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/17:0cycw7)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(9Z))326
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/19:0cycw7)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/19:0cycw7/16:0)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/19:0cycw7/18:1(9Z))323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/19:0cycw7/19:0cycw7)323

Research

Studies (155)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (2.58)18.7374
1990's21 (13.55)18.2507
2000's33 (21.29)29.6817
2010's87 (56.13)24.3611
2020's10 (6.45)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.28 (24.57)
Research Supply Index5.06 (2.92)
Research Growth Index5.34 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.64%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other156 (99.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]